Common variants in the regulative regions of <it>GRIA1 </it>and <it>GRIA3 </it>receptor genes are associated with migraine susceptibility
<p>Abstract</p> <p>Background</p> <p>Glutamate is the principal excitatory neurotransmitter in the central nervous system which acts by the activation of either ionotropic (AMPA, NMDA and kainate receptors) or G-protein coupled metabotropic receptors. Glutamate is widel...
Main Authors: | Gianfrancesco Fernando, Griffiths Lyn R, Diodato Daria, Farina Olimpia, Sampaolo Simone, Aloia Andrea, Formicola Daniela, Di Iorio Giuseppe, Esposito Teresa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/11/103 |
Similar Items
-
Experiences with GRIA - Industrial Applications on a Web Services Grid.
by: Surridge, M, et al.
Published: (2005) -
GRIA3 p.Met661Thr variant in a female with developmental epileptic encephalopathy
by: Satomi Okano, et al.
Published: (2023-02-01) -
Unraveling genetic modifiers in the gria4 mouse model of absence epilepsy.
by: Wayne N Frankel, et al.
Published: (2014-07-01) -
P268: A functionally uncharacterized, novel GRIA2 variant: Advances in targeted epilepsy management
by: Reilly Philliben
Published: (2023-01-01) -
Mutation in the GRIA4 Gene Presenting as ESES: Expanding the Genetic Landscape of ESES
by: Indar K. Sharawat, et al.
Published: (2024-05-01)